In a report published Wednesday, Deutsche Bank reiterated its Hold rating on Johnson & Johnson JNJ, and raised its price target from $72.00 to $75.00.
Deutsche Bank noted, “3Q12 beats; Maintain Hold Rating. J&J's 3Q12 EPS of $1.25 were better than expected on a slightly higher topline and lower SG&A expenses. Excluding FX and Synthes, sales were up 5%, which marks the best quarter in a number of years as J&J anniversaries patent expirations and sees growth driven by new product launches. The MD&D businesses continue to see more modest growth due to muted utilization trends. While our EPS forecasts and rating (Hold) are unchanged, we are raising our price target to $75 (from $72) to reflect a sum-of-the-parts peer valuation.”
Johnson & Johnson closed on Tuesday at $69.55.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in